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It has been demonstrated that human immunodeficiency virus type 1 (HIV-1) virions are biochemically active particles,
within which reverse transcription can take place even in physiological microenvironments. This process has been termed
‘‘natural endogenous reverse transcription’’ (NERT). In this report, we demonstrate that purified virions of simian immunodefi-
ciency virus (SIV) also contain virus-specific DNA, which resulted from partial reverse transcription. Further, viral DNA
synthesis could be initiated in SIV virions in the presence of polyamines and deoxyribonucleoside triphosphates (dNTPs),
at physiological concentrations. The viral infectivity upon initially quiescent cells was significantly increased, when the levels
of intravirion reverse transcripts were modulated. These data suggest that NERT of SIV may play an important role for SIV
pathogenesis and transmission. In contrast to HIV-1, these hypotheses may be further directly investigated by in vivo model
systems. q 1997 Academic Press
Although genomic RNA dominates in the cell-free viri- cytes (PBL) and monocyte/macrophages. Conversely, az-
idothymidine (AZT) treatment of cells producing HIV-1ons of human immunodeficiency virus type 1 (HIV-1) as
the primary intravirion genetic substance, quantities of virions leads to viral particles with decreased intravirion
partial reverse transcripts and also decreased viral infec-intravirion reverse transcripts were identified in both cell
cultures and in the physiological fluids of HIV-1-infected tivity upon initially quiescent PBL (6). As NERT is potently
enhanced in the seminal plasma, we predicted that theseindividuals (1 – 5). Although intravirion DNA is mainly par-
tial reverse transcripts in cell-culture and blood plasma, molecular events may play important roles in the sexual
transmission of this human lentivirus.high levels of full-length reverse transcripts are found
within virions obtained from seminal plasma of HIV-1- The simian immunodeficiency viruses (SIV) are nonhu-
man primate lentiviruses, which are related to HIV-1 ininfected individuals (5, 6). This phenomenon is due to
the reverse transcription occurring within intact virions. genomic organization and biological properties. SIV was
first isolated from captive macaques with immunodefi-We have demonstrated that the addition of deoxyribo-
nucleoside triphosphates (dNTPs) to isolated HIV-1 viri- ciency syndromes or lymphomas. Conversely, SIVs were
found to asymptomatically infect a variety of Old Worldons can drive intravirion DNA synthesis, leading to higher
levels of intravirion reverse transcripts (6). Polyamines, primate species, including sooty mangabeys, African
green monkeys, and mandrills (10). Investigation of SIVwhich are essential for chromosomal DNA replication in
vivo (7, 8), have also been shown to enhance intravirion pathogenesis and transmission has provided a valuable
animal model for the acquired immunodeficiency syn-reverse transcription. As endogenous reverse transcrip-
tion can take place in physiological microenvironments, drome (AIDS) in humans, allowing the study of both sus-
ceptible and resistant monkey species (10). As the im-this process has been termed natural endogenous re-
verse transcription (NERT) (6). pact of NERT upon sexual transmission of HIV-1 is diffi-
cult to directly demonstrate in vivo, we asked whetherIntravirion reverse transcription has been shown to be
a dynamic process in the blood plasma of HIV-1-infected SIV virions express intravirion reverse transcripts which
could be dynamically altered by NERT in vitro, and poten-individuals, which responds to reverse transcriptase in-
hibitor treatment (9). Further studies have demonstrated tially in vivo, toward understanding the implications of
this molecular mechanism on the sexual transmission ofthat altering intravirion reverse transcription, with certain
physiological substances, potently alters HIV-1 infectivity HIV-1.
In this report, we demonstrate that intravirion reverseupon initially quiescent human peripheral blood lympho-
transcripts could also be identified in the SIVmac251 virions.
NERT in SIV could be initiated in physiological microenvi-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (215) 923-1956. ronments and positively altered viral infectivity. There-
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FIG. 1. Copurification of SIV virions and partial reverse transcripts detected by dual equilibrium density centrifugation. The supernatant of SIVmac251-
infected cell-line, CEMX174/SIVmac251 , was collected and treated with DNase and RNase. The viral suspension was then placed onto a 20 to 70%
sucrose gradient and centrifuged at 35,000 rpm for 20 hr in a SW41 rotor. The gradient was then fractionated into 17 tubes. The fraction with a
density of 1.16 g/ml was diluted with TN buffer and further placed onto another 20 to 70% sucrose gradient for a second centrifugation, as mentioned
above. The gradient was then fractionated. Analysis of SIV p27 antigen via ELISA, and viral DNA by PCR amplification with a variety of primer pairs,
was performed.
fore, the relationship of NERT and sexual transmission of was treated with 20 Units of RQ1 DNase and 10 Units
of RNase-1 (Promega, Madison, WI) at 377 for 1 hr. ToHIV-1 may be further investigated using the SIV/primate
model system. remove the DNase and RNase, the sample was then
diluted with 80 ml of cold PBS and centrifuged at 45,000Intravirion DNA can be detected in cell-free SIV virions.
To demonstrate intravirion reverse transcripts in cell cul- g for 1 hr. The viral pellet was resuspended in 0.5 ml of
TN buffer and placed on top of a 20 to 70% sucrosetures, SIV virions were purified by two rounds of equilib-
rium density centrifugation, after treatment with DNase gradient and centrifuged at 150,000 g for 20 hr at 47 in
a Beckman SW41 rotor. The gradient was then collectedand RNase. The SIVmac251 strain (11) was grown in a CD4-
positive T-lymphocyte cell-line (CEMX174). The CEMX174 into 17 tubes. The fraction which had a density of 1.16
g/ml was diluted with TN buffer and was again placedcells were washed with cold phosphate-buffered saline
(PBS) and then were resuspended in RPMI-1640 medium on the top of another 20 to 70% sucrose gradient and
centrifuged in the same conditions. Again, the gradient(GIBCO-BRL, Inc., Grand Island, NY) containing 10% fetal
bovine serum (FBS) and cultured for 3 days at 377 and was collected into 17 fractions and 50 ml from each was
analyzed for SIV p27 antigen, gravity density, and viral5% CO2 . After the cell pellet was obtained by centrifuga-
tion at 500 g for 10 min, the supernatant was passed nucleic acids. As shown in Fig. 1, the buoyant density
(1.16 g/ml) clearly demonstrated SIV virions, measuredthrough a 0.45-m pore size filter and centrifuged at 45,000
g for 1 hr, using an Ti60 rotor (Beckman, Inc., Palo Alto, by SIV p27 antigen, separate from other cellular particles.
The data, illustrated in the lower panel of Fig. 1, consistCA). The viral pellet was resuspended in 1 ml of TN
buffer (10 mM Tris–HCl, 100 mM NaCl). This preparation of the polymerase chain reaction (PCR)-amplified viral
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FIG. 2. Second DNase treatment of isolated SIV virions. Purified SIV virions, described in the legend of Fig. 1, were treated without (lane 1) or
with DNase (lane 2), and 1% Triton-X100 followed by DNase (lane 3); As a control, plasmid SIV DNA was mixed with DNase (lane 4) or left untreated
(lane 5). Further, purified SIV virions were mixed with plasmid SIV DNA and treated with DNase (lane 6). After heat-inactivating DNase, the viral
DNA was extracted and amplified by PCR with the SIV38/SIV39 primer pair. The PCR product was detected using a 32P-labeled SIV19 probe and
visualized by autoradiography.
DNA, in the aliquots from harvested fractions, utilizing SIV39 primer pair is: 5*-GAGACACCTAGTGGTGGAAAC-
AGGAACAGC-3* (nucleotides 1355 to 1385). The se-different primer pairs. PCR analysis was performed three
times on all fractions, from the equilibrium density gradi- quences and the locations of the primer pairs/probes
are based upon the sequence of SIVmac251 , as publishedent, to exclude the possibility of contamination.
For PCR analysis, the viral DNA was extracted by a previously (11). The PCR products were separated by
electrophoresis on 1.5% agarose gels and transferred‘‘quick lysis’’ method, as previously described (5). PCR
was performed using 30 cycles with the SIV667/SIV55 onto nylon membranes, followed by hybridizing with 32P-
labeled probes. After washing off the unattached probe,primer pair for viral DNA in the R-U5 region, SIV38/SIV39
primer pair for viral DNA in the gag region, and SIV667/ the blots were visualized with autoradiography.
Further, Fig. 2 indicates that the virion-associated DNASIV661 primer pair for the region in the RU5, primer bind-
ing site (PBS) and 5*-noncoding region (5NC), which is DNase-resistant (lanes 1 and 2), whereas plasmid
SIVmac251 DNA was DNase-sensitive under the same con-demonstrates the synthesis of positive-strand viral DNA.
The sequences and locations in the SIVmac251 proviral ditions (lane 4). Detergent treatment of the virions, to
disrupt the viral envelope, converts the DNase-resistant,genome for SIV667 and SIV55 are: 5*-GCTGCCATTTTA-
GAAGTA-3* (nucleotides 665 to 683) and 5*-GGATTT- virion-associated DNA to DNase-sensitive (lane 3).
Therefore, it was concluded that this virus-specific DNATCCTGCTTCGGT-3* (nucleotides 783 to 801), respec-
tively. The sequence for SIV661 is: 5*-CCTTCACTCAGC- was within viral particles of SIV.
The ratio of SIV strong-stop DNA to gag DNA in purifiedCGTACT-3* (nucleotides 850 to 868). The probe SIV31
which detects the PCR product of the SIV667/SIV55 SIV virions was approximately 100:1, as quantitated utiliz-
ing a phosphor-imager (Molecular Dynamics) with stan-primer pair or the SIV667/SIV661 primer pair is: 5*-TGT-
GTTCCCATCTCTCCTAGTCGCCGCCTG-3* (nucleotides dard copy controls (Fig. 1). Further, the ratio of viral geno-
mic RNA to strong-stop and gag viral DNA in SIV virions691 to 720). The sequence for SIV38 is: 5*-TGAGGAAGC-
AAAACAGAT-3* (nucleotides 1331 to 1345); SIV39 is 5*- was quantitated. Viral genomic RNA was measured using
reverse transcriptase (RT)-PCR, as previously describedAGGTGGACATAGTTACCA-3* (nucleotides 1366 to 1383)
and the probe SIV19 for the PCR product of the SIV38/ (5). Figure 3 indicates that the ratio of SIV strong-stop
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FIG. 3. Comparison of the intravirion SIV DNA and RNA levels via quantitative DNA- and RT-PCR. The isolated SIV virions, described in Fig. 1,
were utilized for extraction of intravirion DNA and genomic viral RNA. Viral DNA (left two panels) was serially diluted (1:10) and subjected to PCR
with a variety of primer pairs. Viral RNA (right panel) was treated with DNase and reverse transcribed into cDNA. The cDNA was then serially
diluted (1:10) and subjected to PCR with the SIV38/SIV39 primer pair. The PCR product was detected using the 32P-labeled SIV19 probe and
visualized by autoradiography.
DNA to genomic RNA was roughly 1:103, and the ratio containing supernatant was then aliquoted. dNTPs at var-
ious concentrations, with or without polyamines [sperm-of RNA to SIV gag DNA was approximately equal to 1:105,
in the same diluted samples utilizing PCR. ine (3 mM) and spermidine (0.1 mM)], were added to
samples of the supernatants. As a control, melittin (5To prepare RNA standards, the SIV gag region-specific
primer SIV38 was modified by the addition of T7 RNA mM), a 26-amino acid amphipathic peptide, which has
been routinely utilized to permeabilize retroviral particlespolymerase promoter sequence (5*-TAATACGACTCA-
CTATAGGG-3*) upstream of the 5*-end of the original (13–16), was also added into certain reactions. The con-
centration of MgCl2 was then adjusted to 1 mM. The ERTSIV38 primer sequence, and five bases (GGTCG) were
added upstream of the promoter site for efficient binding reaction was allowed to progress at 377 for 20 hr. The
virions were treated with DNase (10 U/ml) for 15 min.of the RNA polymerase. PCR amplification was per-
formed with the modified primer RPSIV38 and primer After the DNase was heat-inactivated, the viral DNA was
then extracted and amplified by PCR, with the primerSIV39. The amplified product was purified and utilized
as template for gag RNA synthesis. The gag RNA was pairs SIV38/SIV39. Analysis by Southern blotting was per-
formed, as described previously (4, 5). As indicated insynthesized according to a described method (12). After
treatment with DNase, twice, to eliminate the template Fig. 4A, the efficiency of intravirion SIV DNA synthesis
depended upon the concentration of dNTPs. Polyamines,DNA, gag RNA was purified on 1.5% agarose gels, seri-
ally diluted, and calibrated. This in vitro-transcribed RNA at physiological concentrations found in human seminal
fluids (7, 8), could largely enhance the intravirion SIVwas utilized as a standard in RT-PCR reactions, to esti-
mate the viral RNA genomic copies in SIV virions. reverse transcription.
To examine the influence of physiological fluids uponNERT can be initiated in SIV virions. To confirm that
NERT in SIV was not due to envelope damage by an SIV NERT, human blood plasma and seminal plasma
from HIV-1-seronegative individuals were mixed with SIVartificial process (e.g., ultracentrifugation of virions),
NERT was initiated prior to virion isolation, as previously virions. After a 20-hr incubation, nascent DNase-resistant
viral DNA was detected (Fig. 4B). As the concentrationdescribed (6). Briefly, after growth in fresh, conditioned
medium for 2 days, the virus-producing cells (CEMX174) of dNTPs and polyamines in the seminal plasma is higher
than in blood plasma (6), the efficiency of intravirion len-were pelleted at 300 g for 10 min. The SIVmac251 virion-
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FIG. 4. NERT in SIV virions. (right panel) Endogenous SIV reverse transcription was analyzed prior to virion isolation and measured using a
quantitative DNA-PCR methodology (17). SIVmac251 virions, obtained from the fresh supernatant of chronically infected CEMX174 cells, were treated
in vitro with various concentrations of dNTPs, with or without polyamines or melittin. The viral DNA was then extracted and analyzed by PCR and
Southern blotting for intravirion SIV gag DNA. Lanes 1 to 4, dNTPs and polyamines (spermine 3 mM, spermidine 0.1 mM); Lanes 5 to 8, dNTPs
alone; Lanes 9 to 12, dNTPs and melittin (5 mM). Lanes 13–17, Standard curve of SIV DNA. SIV virions were mixed with human blood plasma,
seminal plasma, or left untreated (volume ratio 1:4) (left panel). After the virions were pelleted by ultracentrifugation, viral DNA was extracted and
analyzed by PCR and Southern blotting for intravirion SIV gag DNA. Lane 1, SIV virions only; Lane 2, SIV virions mixed with blood plasma; Lane 3,
SIV virions mixed with seminal plasma. Lanes 4 to 8, standard curve of SIV DNA.
tiviral reverse transcription was concomitantly higher in PCR, and SIV p27 antigen levels by ELISA. These super-
natants were serially diluted (1:4) and added to quiescentthe SIV virions mixed with seminal plasma, as compared
to virions mixed with blood plasma. PBL from healthy, HIV-1-seronegative individuals. The
SIV infections were allowed to progress for 4 hr. TheViral infectivity in quiescent cells is altered by intravi-
unbound viruses were then removed, via three washesrion SIV reverse transcripts. To determine the impact of
with PBS. The infected cells (106) were cultured in dupli-intravirion DNA upon viral infectivity, the intravirion SIV
cate, in 2 ml of RPMI-1640 media plus 10% FBS. Afterreverse transcripts identified in the supernatants of cell
overnight incubation, the supernatants (0.5 ml) were col-cultures were greatly decreased by treating the virus-
lected for SIV p27 antigen analysis, on Day 0. Five daysproducing cells with AZT. The SIV-producing cells were
postinfection, phytohemagglutinin (PHA; 5 mg/ml, Sigma)treated with AZT (10 mM) or left untreated and incubated
and natural human interleukin II (IL-2; 50 U/ml; GIBCO-at 377 for 2 days. The cells were centrifuged and the
BRL) were added. On the eighth day postinfection, PHAvirions in the supernatants were treated with DNase and
and IL-2 were washed off by pelleting the infected cellspassed through 20% sucrose in a Ti60 rotor at 90,000 g
by low-speed centrifugation. The cells were then culturedfor 1 hr, to wash off AZT and DNase. The viral pellets
in 2 ml of RPMI-1640 media plus 10% FBS with IL-2 (10 U/were divided into two parts, and one aliquot was used
ml). Portions of the supernatants (0.5 ml) were collected,to estimate partial reverse transcripts by PCR, using dif-
every 3–4 days, until 28 days poststimulation. The SIVferent primer pairs. As indicated in Fig. 5, treatment with
p27 antigen levels were quantitated by ELISA (Coulter,AZT of the virus-producing cells potently decreased in-
FL). As indicated in Table 1, infectivity of SIV virions ontravirion SIV partial reverse transcripts. Another aliquot
initially quiescent PBL, after treatment with AZT (10 mM),was utilized in an infectivity assay, upon initially quies-
was decreased by approximately 16-fold.cent PBL. In the infectivity assays, the viral input was
normalized both by genomic RNA, via quantitative RT- Conversely, as dNTPs and polyamines enhance NERT,
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FIG. 5. The influence of AZT treatment of SIV-producing cells on intravirion reverse transcripts. Virus-producing T-lymphocytic cells (CEMX174)
were treated with AZT (10 mM) or left untreated. After 2 days of culture, the SIV virions in the supernatants were then analyzed by: Quantitative
DNA-PCR for intravirion SIV DNA (upper two panels). Lane 1, SIV virions from cells left untreated; Lane 2, SIV virions from cells treated with AZT
(10 mM). Lanes 3 to 7, SIV DNA standard curve. Quantitative RT-PCR for intravirion genomic SIV RNA (dilution 1:103) (lowest panel). Lane 1, SIV
virions from cells left untreated; Lane 2, SIV virions from cells treated with AZT (10 mM); Lanes 3 to 7, genomic SIV RNA standard curve.
we asked if higher levels of intravirion DNA, resulting unbound viruses were removed, via three vigorous
from the treatment of SIV virions with dNTPs and/or poly- washes with PBS. The infected cells (2 1 106) were then
amines, could increase viral infectivity. To this end, the cultured, in duplicate, in 2 ml of RPMI-1640 medium plus
SIVmac251 virions in the fresh supernatants of virus-pro- 10% FBS. After overnight incubation, the supernatants
ducing T-lymphoid cells (CEMX174) were mixed with (0.5 ml) were collected for SIV p27 antigen detection on
dNTPs (50 nM) and polyamines (3 mM spermine, 0.1 mM Day 0. Forty-eight hours postinfection, PHA (5 mg/ml) and
spermidine) or left untreated. After incubation at 377 for natural human IL-2 (50 Units/ml) were added to the cul-
20 hr, the mixtures were placed onto a 20% sucrose-TN tures. On the fifth day postinfection, the PHA and IL-
solution and virions were then pelleted in a Ti60 rotor at 2 were washed off by pelleting the infected cells via
90,000 g for 1 hr. The virions were resuspended in RPMI- centrifugation. The cells were then cultured in 2 ml of
1640 media and allowed to infect 4 1 106 quiescent PBL RPMI-1640 medium plus 20% FBS with IL-2 (10 Units/
from HIV-1-seronegative individuals, at 377 for 4 hr. The ml). The supernatants were collected at specified time-
points. The SIV p27 antigen levels were quantitated by
ELISA. Table 2 demonstrates that viral infectivity upon
TABLE 1 quiescent cells increased by approximately 16-fold after
Effect of AZT-Treatment of SIVmac251-Producing Cells incubation with dNTPs and polyamines, suggesting an
upon Viral Infectivity important role for SIV virions harboring reverse tran-
scripts in enhancing virus infectivity.SIV p27 antigen expressiona
Intravirion SIV DNA in the supernatants of cell cultures,
Day 33 identified in this study, was demonstrated by its copurifi-
Day 0 (postinfection) cation with SIV virions in the ‘‘double-banding’’ purifica-
tion process, resistance to DNase treatment of the intact
AZT AZT
viral particles, and sensitivity after lysis of virions. Con-SIV viral input Untreated 10 mM Untreated 10 mM
versely, AZT treatment of the SIV-producing cells de-
1:1 (72 ng of p27) 0 0 //// //// creased the quantity of viral DNA present within virions,
1:4 0 0 //// //// and the copy number of viral DNA moieties in early
1:16 0 0 //// ////
phases of reverse transcription was higher than the in-1:64 0 0 //// ////
travirion reverse transcriptase of late phases, indicating1:256 0 0 //// 0
1:1024 0 0 // 0 that the viral DNA is the result of partial SIV reverse
1:4096 0 0 0 0 transcription. These results are consistent with other dis-
tinct retroviruses, such as HIV-1 and Moloney murinea The cutoff for negative (0) was 0.25 ng/ml; for positive (/) was
leukemia virus (MMLV) virion particles (1–5, 17).0.25 –0.5 ng/ml; for (//) was 0.5–1.0 ng/ml; for (///) was 1–2 ng/
ml; and for (////) was 2 ng/ml of SIV p27 antigen by ELISA. Similar to HIV-1, SIV virions have now been demon-
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TABLE 2
The Impact of NERT upon SIV Infectivity
SIV p27 antigen expressiona
Day 0 Day 30 (postinfection)
/ dNTPs / dNTPs
SIV viral input Untreated / Polyamines Untreated / Polyamines
1:1 (25 ng of p27) 0 0 //// ////
1:4 0 0 //// ////
1:16 0 0 0 ////
1:64 0 0 0 ///
1:256 0 0 0 0
a The cutoff for negative (0) was 0.25 ng/ml; for positive (/) was 0.25–0.5 ng/ml; for (//) was 0.5–1.0 ng/ml; for (///) was 1–2 ng/ml; and
for (////) was 2 ng/ml of SIV p27 antigen by ELISA.
strated to be biochemically active particles. NERT, in SIV, onstrated that viral infectivity upon initially quiescent
cells could be altered by modulating the levels of intravi-can be initiated in the presence of dNTPs and poly-
amines at physiological concentrations. Therefore, this rion HIV-1 reverse transcripts (6). In this study, intravirion
reverse transcripts of SIV also have been shown to beproperty of SIV virions is influenced by their microenvi-
ronment. Based upon these characteristics, we suggest important for viral infectivity upon quiescent cells. It has
been demonstrated that the major target cells for sexualthat the intravirion SIV reverse transcripts identified in
cell cultures are the result of NERT. The reverse tran- transmission of SIV in the submucosal tissue of the geni-
tal tract of macaques are quiescent dendritic cells orscriptase in the virions would use dNTPs, packaged from
the virus-producing cells or ingressed from the superna- mononuclear cells (21, 22). As such, an increased infec-
tivity of this lentivirus in seminal fluid caused by NERTtant, to synthesize partial reverse transcripts. As indi-
cated in Fig. 4A, the higher the levels of dNTPs present could enhance the sexual transmission rate. It is notable
that the transmission rate of SIV to rhesus macaquesin microenvironment, the more intravirion SIV reverse
transcripts were detected. As demonstrated previously, increases if the intravaginal inoculation of cell-free SIV
virions is mixed with seminal plasma, rather than mixedpolyamines can potently enhance both exogenous re-
verse transcription and endogenous reverse transcrip- with conditioned medium (23). This may be partially due
to seminal plasma neutralizing the acidity in the femaletion (6). As seminal plasma harbors high levels of the
polyamines (7, 8), seminal plasma could support NERT genital tract and increasing the stability of virions. How-
ever, it is also quite possible that NERT potently occurredin SIV (Fig. 4B).
It has been recently demonstrated that the HIV-1 enve- in the seminal fluids, such that the infectivity of cell-free
virions was enhanced. To examine this issue in vivo,lope is permeable to dNTPs via amphipathic domains in
the C-terminus of gp41 (18). There are also two amphi- animal model systems with select primate species and
SIV are currently under investigation by our laboratories.pathic domains in the C-terminus of gp41 in SIV (19 and
our unpublished data). These motifs may permeabilize
the viral envelope to dNTPs. It is notable that the SIVmac251 ACKNOWLEDGMENTS
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